Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of a Trivalent Influenza Vaccine in Patients With Chronic Kidney Disease Undergoing Hemodialysis: MF59-adjuvanted Versus Non-adjuvanted Vaccines

NCT02686398 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT02686398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of a Trivalent Influenza Vaccine in Patients With Chronic Kidney Disease Undergoing Hemodialysis: MF59-adjuvanted Versus Non-adjuvanted Vaccines
Lead sponsor
Korea University Guro Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
November 30, 2014
Enrollment
174 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, end stage renal failure, influenza